Stay updated with breaking news from Kronos Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MIT spinout Kronos Bio, founded by Associate Professor Angela Koehler, studies the complex signaling networks of cancer cells to find new drug targets. Proteins called transcription factors are like...
The MIT spinout Kronos Bio, founded by Associate Professor Angela Koehler, studies the complex signaling networks of cancer cells to find new ways to stop their growth.
Kronos Bio (NASDAQ:KRON – Get Free Report) had its price target reduced by analysts at HC Wainwright from $10.00 to $9.00 in a report released on Monday, Marketbeat.com reports. The firm presently has a “buy” rating on the stock. Kronos Bio Price Performance Shares of KRON stock opened at $1.42 on Monday. The business has […]
Kronos Bio (NASDAQ:KRON – Free Report) had its target price trimmed by HC Wainwright from $10.00 to $9.00 in a research note released on Monday, MarketBeat reports. The brokerage currently has a buy rating on the stock. Kronos Bio Trading Down 1.4 % Shares of Kronos Bio stock opened at $1.42 on Monday. The company […]
Key Insights Given the large stake in the stock by institutions, Kronos Bio's stock price might be vulnerable to their...